Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
54.2%
% of PJP's 24 holdings also in XPH
35.1%
% of XPH's 40 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 6.0% | 5.6% | 5.6% |
|
MERCK & CO. INC. | 5.8% | 4.2% | 4.2% |
|
JOHNSON & JOHNSON | 5.6% | 4.0% | 4.0% |
|
PFIZER INC | 5.4% | 3.8% | 3.8% |
 |
JAZZ PHARMACEUTICALS PLC | 3.3% | 4.5% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to XPH
|
ABBVIE INC | 6.0% |
|
AMGEN INC | 5.9% |
|
GILEAD SCIENCES INC | 5.8% |
|
ABBOTT LABORATORIES | 5.6% |
|
TRAVERE THERAPEUTICS, INC. | 3.7% |
 |
VALEANT PHARMACEUTICALS INT'L | 3.6% |
 |
TARO PHARMACEUTICAL INDUS | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.4% |
|
GERON CORP | 3.4% |
|
BIOGEN IDEC INC | 3.4% |
PJP Underweight Relative to XPH
|
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% |
|
ELANCO ANIMAL HEALTH, INC. | -5.7% |
|
CATALENT INC | -5.5% |
|
ZOETIS INC | -4.8% |
|
VIATRIS, INC. | -4.5% |
|
AXSOME THERAPEUTICS, INC. | -4.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.9% |
|
ORGANON & CO. | -3.8% |
|
ROYALTY PHARMA PLC CLASS A | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |